TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MCRB

Seres Therapeutics Inc

Healthcare · Biotechnology

4.00$ -2.4% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Seres Therapeutics Inc (MCRB): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/04/2026.

Next report 11/04/2026
Last report 08/05/2026
Earnings surprise by quarter (%)
Q3 23 · 30.5 % 23 Q4 23 · 36.0 % 23 Q1 24 · 25.5 % 24 Q2 24 · 25.6 % 24 Q3 24 · -16,400.0 % 24 Q4 24 · 44.8 % 24 Q1 25 · -213.7 % 25 Q2 25 · 0.0 % 25 Q3 25 · 1,780.0 % 25 Q4 25 · -10.0 % 25 Q1 26 · -10.6 % 26 Q2 26 · 27.5 % 26

EPS estimate beaten

Full history 21 of 45 quarters (47%)
Last 16 quarters 7 of 16 quarters (44%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/05/2026 Seres Therapeutics, Inc. (MCRB): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/04/2026 Seres Therapeutics, Inc. (MCRB): Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/08/2026 Seres Therapeutics, Inc. (MCRB): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/08/2026 Seres Therapeutics, Inc. (MCRB): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?